Investor Overview

Corporate ProfilescPharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing products that, through our proprietary platform, are designed to enable the subcutaneous administration of therapies previously limited to intravenous (IV) delivery — with the goal of transforming infused therapies, advancing patient care and reducing healthcare costs.
Stock Quote SCPH (Common Stock) $13.67 + 0.60 (4.59%)
ExchangeNASDAQ
Volume40,429
Today's Open$13.07
Previous Close$13.07
Data as of 05/21/18 12:05 p.m. ET

Data provided by Nasdaq. Minimum 15 minutes delayed.

Stock Chart
Stock chart for: SCPH.O.  Currently trading at $13.67 with a 52 week high of $18.17 and a 52 week low of $8.89.
Current News

May 07, 2018

scPharmaceuticals Inc. Reports First Quarter 2018 Financial Results and Provides Business Update

Company’s lead investigational product, FUROSCIX®, has a PDUFA date of June 23, 2018 Company has initiated staged commercialization activities for FUROSCIX BURLINGTON, Mass., May 07, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs, today announced financial results for the first qua

Read More >

Mar 20, 2018

scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results

Announced $147.7 Million of equity capital raising in 2017;  Completed an Initial Public Offering;  Advances towards FUROSCIX™ PDUFA date BURLINGTON, Mass., March 20, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize delivery of infused therapies, advance patient care and reduce healthcare costs, today announced financial results for the fourth quarter and full year

Read More >

Mar 01, 2018

scPharmaceuticals Inc. to Present at the Cowen 38th Annual Health Care Conference

BURLINGTON, Mass., March 01, 2018 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq:SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused therapies, advance patient care and reduce healthcare costs, today announced that John Tucker, president and chief executive officer and Troy Ignelzi, chief financial officer of scPharmaceuticals, will present at the Cowen 38th Annual Health Care Conference at 10:40 a.m. ET on Wednesd

Read More >

Upcoming Events
There are currently no events scheduled.